首页> 外文期刊>Respiratory Medicine Case Reports >Chinese herbal medicine Qing-Dai-induced pulmonary arterial hypertension in a patient with ulcerative colitis: A case report and experimental investigation
【24h】

Chinese herbal medicine Qing-Dai-induced pulmonary arterial hypertension in a patient with ulcerative colitis: A case report and experimental investigation

机译:中药清代诱发溃疡性结肠炎肺动脉高压:一例报告及实验研究

获取原文
       

摘要

A recent case report described a case of pulmonary arterial hypertension (PAH) associated with use of the Chinese herbal medicine Qing-Dai; however, the clinical course and possible mechanisms have not been characterized. We present the case of a man with ulcerative colitis who was diagnosed with idiopathic PAH. After initiating oral beraprost therapy, the patient showed significant hemodynamic improvements and an unusual course of clinical recovery. In 2016, the Japanese Ministry of Health, Labour, and Welfare issued a warning regarding the possible side effects of Qing-Dai. We learned that our patient had been taking self-purchased Qing-Dai for 2 years. Therefore, we performed an experimental study and determined that Qing-Dai may cause PAH through a mechanism involving nitric oxide synthase inhibition and pulmonary artery endothelial dysfunction.
机译:最近的一例病例描述了与使用中草药青黛有关的肺动脉高压(PAH)病例。然而,临床过程和可能的机制尚未被表征。我们介绍了一例患有溃疡性结肠炎的男子,该男子被诊断为特发性PAH。开始口服贝拉前列素治疗后,患者表现出明显的血液动力学改善和异常的临床恢复过程。 2016年,日本厚生劳动省发出了关于青黛可能产生的副作用的警告。我们了解到,该患者已经服用了自购的青黛产品已有2年了。因此,我们进行了一项实验研究,并确定青黛可能通过一氧化氮合酶抑制和肺动脉内皮功能障碍的机制引起PAH。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号